Transplantation of human umbilical cord-derived endothelial progenitor cells promotes re-endothelialization of the injured carotid artery after balloon injury in New Zealand white rabbits

Chinese Medical Journal

Volumn 126, Issue 8, 2013, Pages 1480-1485

  Hu, Cheng Heng ^a   Ke, Xiao ^a   Chen, Kui ^a   Yang, Da Ya ^a   Du, Zhi Min ^a   Wu, Gui Fu ^b,c  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c Futian Hospital   (China)

Author keywords

Cell transplantation; Endothelial progenitor cell; Neointimal; Umbilical cord blood

Indexed keywords

CD31 ANTIGEN; CELL NUCLEUS ANTIGEN; CYTOKINE; HEPARIN; MESSENGER RNA; PENICILLIN DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON CATHETER; BLOOD VESSEL INJURY; CAROTID ARTERY INJURY; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPERPLASIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MONONUCLEAR CELL; MORPHOMETRICS; NEOINTIMA; NEW ZEALAND; NONHUMAN; PATHOLOGY; PROTEIN EXPRESSION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CAROTID ARTERY INJURIES; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; ENDOTHELIAL CELLS; FETAL BLOOD; HUMANS; HYPERPLASIA; MALE; NEOINTIMA; PROLIFERATING CELL NUCLEAR ANTIGEN; RABBITS; RNA, MESSENGER; STEM CELL TRANSPLANTATION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84876385558     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20122355     Document Type: Article

References (20)

1. Siasos G, Tousoulis D, Antoniades C. l-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis. Int J Cardiol 2008; 126: 394-397.
2. Gulati R, Jevremovic D, Peterson TE, Witt TA, Kleppe LS, Mueske CS. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation 2003; 108: 1520-1526.
3. Werner N, Priller J, Laufs U, Endres M, Böhm M, Dirnagl U, et al. Bone marrow-derived progenitor cells modulate vascular re-endothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vase Biol 2002; 22: 1567-1572.
4. Isner J, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 1999; 103: 1231-l236.
5. Lenfant C. Cardiovascular research: a look into tomorrow. Circ Res 2001; 88: 253-255.
6. Asahara T, Murohara T, Sullivan A. Isolation of putatitve progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
7. Murohara T, Ikeda H, Duan J. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. Clin Invest 2000; 105: 1527-1536.
8. Goodwin HS, Bicknese AR, Chien SN. Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant 2001; 7: 581-588.
9. Hu CH, Li ZM, Du ZM, Wu GF, Wang XQ. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction. Chin Med J 2006; 119: 1499-1506.
10. Hu CH, Li ZM, Du ZM. Human umbilical cord-derived endothelial progenitor cells promote growth cytokines-mediated neorevascularization in rat myocardial infarction. Chin Med J 2009; 122: 548-555.
11. Gehling UM, Ergun S, Schurnaeher U. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 5: 3106-3112.
12. Murohara T, Ikeda H, Duan J. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105: 1527-1536.
13. Vasa M, Fichtlscherer S, Aicher A. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Cir Res 2001; 89: E1-E7.
14. Kauahal S, Amierl GE, Guleserian KJ. Functional small-diameter neovessels created using endothelial progenitor cell expanded ex vivo. Nat Med 2005; 7: 1035-1040.
15. Kong D, Melo LG, Mangi AA. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 2004; 109: 1765-1775.
16. Saleh N, Svane B, Jensen J. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris. Am Heart J 2005; 149: 876-872.
17. Ruiz-Ortega M, Rodrguez-Vita J, Sanchez Lopez E. TGF-beta signaling in vascular fibrosis. Cardiovasc Res 2007; 74: 196-206.
18. Flynn AW, Chen X, O'Connell E, O'Brien T. A comparison of the efficacy of transplantation of bone marrow derived mesenchymal stem cells and unrestricted somatic stem cells on outcome after acute myocardial infarction. Stem Cell Res Ther 2012; 3: 36.
19. Kuraitis D, Ebadi D, Zhang P, Rizzuto E, Vulesevic B, Padavan DT, et al. Injected matrix stimulates myogenesis and regeneration of mouse skeletal muscle after ischaemic injury. Eur Cell Mater 2012; 24: 175-196.
20. Reis LA, Borges FT, Simões MJ, Borges AA, Sinigaglia-Coimbra R, Schor N. Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats. PLoS One 2012; 7: e44092.